Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is BATM Advanced Communications EV-to-EBITDA?
BATM Advanced CommunicationsLSE:BVC +4.78%41 EV-to-EBITDA is 2.51 as of Jul. 20, 2026, which is 85% below its 10-year median of 16.69. GuruFocus rates LSE:BVC with a GF Score™ of 41/100 and a GF Value™ of £0.17 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 510 Medical Devices & Instruments companies, BATM Advanced Communications ranks better than 96.47% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BATM Advanced Communications's enterprise value is £35.29 Mil.
BATM Advanced Communications's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was £14.05 Mil. Therefore, BATM Advanced Communications's EV-to-EBITDA for today is 2.51.
The historical rank and industry rank for BATM Advanced Communications's EV-to-EBITDA or its related term are showing as below:
LSE:BVC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.05 Med: 16.69 Max: 86.53
Current: 2.51
During the past 13 years, the highest EV-to-EBITDA of BATM Advanced Communications was 86.53. The lowest was -15.05. And the median was 16.69.
LSE:BVC's EV-to-EBITDA is ranked better than 96.47% of 510
companies
in the Medical Devices & Instruments industry
Industry Median: 14.155
vs LSE:BVC: 2.51
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BATM Advanced Communications's PE Ratio (TTM) for today is calculated as:
BATM Advanced Communications's share price for today is £0.1425.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BATM Advanced Communications's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £-0.031.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:BVC vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's EV-to-EBITDA falls into.
BATM Advanced Communications's current Enterprise Value is £35.29 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BATM Advanced Communications's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was £14.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications (LSE:BVC) has a EV-to-EBITDA of 2.51 as of Jul. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BATM Advanced Communications. This is 85% below median its historical median of 16.69. According to the industry distribution chart, BATM Advanced Communications ranks #18 out of 510 companies in the Medical Devices & Instruments industry, placing it in the top 3.5%.
Is BATM Advanced Communications' EV-to-EBITDA too high?
BATM Advanced Communications' current EV-to-EBITDA of 2.51 is 85% below median its 10-year median of 16.69. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.16. BATM Advanced Communications' value of 2.51 is 82.3% below this industry median. Based on the distribution chart, BATM Advanced Communications ranks #18 out of 510 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BATM Advanced Communications has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #18 out of 510 companies for EV-to-EBITDA. This places BATM Advanced Communications in the top 4% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.16. BATM Advanced Communications' value of 2.51 is 82.3% below this benchmark. While the company's 10-year median is 16.69 vs. the industry median of 14.16, BATM Advanced Communications has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.16, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BATM Advanced Communications's current EV-to-EBITDA of 2.51 is 82.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BATM Advanced Communications. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current EV-to-EBITDA is 2.51, which is 85% below median its own 10-year median of 16.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
Based on GuruFocus' analysis, BATM Advanced Communications (LSE:BVC) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.17, compared to a current price of £0.14 — trading 16.2% below its estimated fair value. The current EV-to-EBITDA is 2.51, which is 85% below median its 10-year median of 16.69 and 82.3% below the Medical Devices & Instruments industry median of 14.16. BATM Advanced Communications' overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For BATM Advanced Communications (LSE:BVC), the current EV-to-EBITDA is 2.51 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BATM Advanced Communications (LSE:BVC) Overvalued in 2026?
Based on GuruFocus' analysis, BATM Advanced Communications stock appears to be undervalued.
The current stock price of £0.14 is trading 16.2% below its estimated GF Value™ of £0.17.
GuruFocus considers BATM Advanced Communications to be Modestly Undervalued.
Key valuation signals for LSE:BVC:
EV-to-EBITDA: 2.51 (85% below median its 10-year median of 16.69)
GF Value™: £0.17 vs. price of £0.14 (16.2% below fair value)
Industry Position: 82.3% below the Medical Devices & Instruments median (#18 of 510)
No single metric tells the full story. See the LSE:BVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
41GF Score
Get the complete analysis for LSE:BVC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BVC has been successfully added to your 
